Neutral Result With Novel Agent in Diabetic Cardiomyopathy ...Middle East

The ARISE-HF trial testing aldose reductase inhibition in asymptomatic diabetic cardiomyopathy did not meet its endpoint but hints at a mechanism that might prevent it. Medscape Medical News

Hence then, the article about neutral result with novel agent in diabetic cardiomyopathy was published today ( Tuesday 16/04/2024 - 02:01 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Neutral Result With Novel Agent in Diabetic Cardiomyopathy )

Also on site :

• MCSO: Three family members abducted from a Perinton residence on Saturday
• Man suspected of abducting three of his family members from a Perinton residence on Saturday
• 26th District Candidates take part in forum